Reaction of [Tp*(CO) 2 MtC-PdC(NMe 2 ) 2 ] [1a, M ) Mo; 1b, W; Tp* ) HB(3,5-Me 2 pz) 3 ] with 2 molar equiv of [Au(CO)Cl] afforded the trinuclear complexes [Tp*(CO) 2 MtC-P(AuCl) 2 C(NMe 2 ) 2 ] 2a (M ) Mo) and 2b (M ) W). In marked contrast to this the arsenic analogues [Tp*(CO) 2 MtC-AsdC(NMe 2 ) 2 ] (3a, M ) Mo; 3b, M ) W), when treated with the gold complex, give rise to AsdC cleavage with formation of the gold carbene complex [ClAuC-(NMe 2 ) 2 ] (5) and the functionalized cyclotriarsanes [{Tp*(CO) 2 MtC-As} 3 ] 4a (M ) Mo) and 4b (M ) W). Compounds 2a,b and 4a,b have been characterized by IR and 1 H and 13 C NMR spectroscopy. In addition, the molecular structures of 2a, 2b, and 5 have been determined by single-crystal X-ray structural analyses.
Et), which have been characterized by IR, IH-, I3C-and 31P-NMR spectroscopy. In addition, the molecular structure of 5b has been elucidated by a single-crystal X-ray structure determination.
Reaction of the carbyne complexes Tp‘(CO)2M⋮C−PC(NR2)2 (1, 2) [Tp‘ = HB(3,5-Me2C3HN2)3; M = Mo (1, 3); W (2, 4); R = Me (a); Et (b)] with methyl trifluoromethanesulfonate
afforded the orange-red salts [Tp‘(CO)2M⋮C−P(Me)C(NR2)2]SO3CF3 (3, 4), the cations of
which can be considered as methylphosphines featuring additional bisaminocarbenium- and
metallaalkynyl substituents. Analogously, complex Tp‘(CO)2W⋮C−PC(NEt2)2 (2b) was
protonated with ethereal HBF4 in ether at the phosphorus atom to give [Tp‘W⋮C−P(H)−C(NEt2)2]BF4 (5), which in CH2Cl2 solution experienced a clean rearrangement to the
metallaphosphirene
(6). Treatment of 2b with F3CSO3H
led directly to
(6‘). The molecular structures of 4b
and 6‘ were established by X-ray structure analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.